Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Ovarian Neoplasms

idarubicin has been researched along with Ovarian Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujii, S; Fukushi, Y; Futagami, M; Higuchi, T; Saito, Y; Sakamoto, T; Sato, S; Takami, H; Yokoyama, Y1
Williams, CJ1
Copeland, LJ; Edwards, CL; Gershenson, DM; Kavanagh, JJ; Saul, PB1
Bruzzone, M; Chiara, S; Conte, PF; Falcone, A; Graziani, G; Rosso, R1
Daghestani, AN; Dougherty, JB; Hakes, TB; Raymond, V; Weiselberg, L1

Other Studies

5 other study(ies) available for idarubicin and Ovarian Neoplasms

ArticleYear
Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2000, Volume: 263, Issue:4

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Cisplatin; Cyclophosphamide; Cystadenocarcinoma, Mucinous; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Liver Neoplasms; Middle Aged; Mitoxantrone; Ovarian Neoplasms; Prednisolone; Remission Induction; Reoperation

2000
A phase II study of oral idarubicin in advanced recurrent or refractory ovarian carcinoma.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:4

    Topics: Administration, Oral; Adult; Aged; Drug Evaluation; Drug Resistance; Female; Humans; Idarubicin; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms

1990
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancer.
    Gynecologic oncology, 1986, Volume: 24, Issue:1

    Topics: Adult; Aged; Daunorubicin; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Idarubicin; Leukocyte Count; Middle Aged; Ovarian Neoplasms

1986
4-Demethoxydaunorubicin (IMI-30) in refractory epithelial ovarian cancer: a pilot study.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Carcinoma; Daunorubicin; Drug Resistance; Female; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms

1987
Phase II study of 4-demethoxydaunorubicin in advanced ovarian carcinoma.
    Cancer treatment reports, 1985, Volume: 69, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Daunorubicin; Drug Evaluation; Female; Granulosa Cell Tumor; Humans; Idarubicin; Middle Aged; Ovarian Neoplasms

1985